Industry

DUBLIN–(BUSINESS WIRE)–The “6-Hour Virtual Seminar on Master Class for the HIPAA Officer: Protecting Patient Information and Implementing Today’s Privacy, Security, and Breach Regulations” webinar has been added to ResearchAndMarkets.com’s offering. Overview: The session begins with overview of the HIPAA regulations and then continues with presentation of the specifics of the Privacy Rule, such as Individual … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Building a Vendor Qualification Program for FDA Regulated Industries” training has been added to ResearchAndMarkets.com’s offering. This course will provide detailed explanations and examples for Building a Vendor Qualification Program for FDA Regulated Industry. With today’s pharmaceutical market, raw materials, Active Pharmaceutical Ingredients (API), Containers & Closures, inactive or excipients and other components … [Read more…]

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today reported that after 5 years of follow-up, Leber Hereditary Optical Neuropathy (LHON) subjects treated with LUMEVOQ® (GS010) continued to experience significantly improved … [Read more…]

Five years since its creation, ATLATL has served more than 100 early-stage biotechs and projects. SHANGHAI–(BUSINESS WIRE)–#Shanghai–Celebrating its 5th anniversary, ATLATL proclaims that it will continue contributing to the rapid growth of the life sciences sector in China. The ATLATL Center for Innovation & Research is a biopharmaceutical research-based open innovation platform committed to building … [Read more…]

No Enhancement of Damages Awarded by Court Despite Jury’s Finding of Willfulness TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Co., Ltd. (TSE: 4568) (hereinafter, Daiichi Sankyo) confirmed today that the U.S. District Court for the Eastern District of Texas has entered judgment on the April 8, 2022 jury verdict finding that ENHERTU® infringes Seagen’s U.S. … [Read more…]

LOS ANGELES & SINGAPORE–(BUSINESS WIRE)–#MedTechInnovator—MedTech Innovator, the largest accelerator of medical technology companies in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry, has announced the 20 companies selected to participate in the organization’s third annual Asia … [Read more…]

Stinging Insect Component Testing Combined with Interpretative Report Offers Enhanced Patient Management BURLINGTON, N.C.–(BUSINESS WIRE)–Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially life-threatening allergic reaction. To help facilitate more effective venom therapy, Labcorp (NYSE: LH), a … [Read more…]

NEW PRAGUE, Minn.–(BUSINESS WIRE)–Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Michelle Wirtz, Interim Chief Financial Officer, are scheduled to participate in the Canaccord Genuity 42nd Annual Growth Conference on August 8-11, 2022. Management will be … [Read more…]

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2022 after the close of trading on Tuesday, August 2, 2022. Company management will host a conference call to discuss financial results beginning at … [Read more…]

QIAGEN Clinical Insights platform growing at over 35% annually, or 700,000 additional cases, and recently breaking through three million cases analyzed and reported Total number of analyzed and reported patient cases using QCI five times higher than other commercial offerings Unique Augmented Molecular Intelligence approach provides customers with the ability to scale NGS testing with … [Read more…]